RhoVac APS
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer (NCT04114825) | RhoVac APS | 2019-11-19 |
| RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours (NCT03199872) | RhoVac APS | 2017-03-30 |
Track RhoVac APS automatically
Every clearance here is in the API, with alerts when new ones post.